Berberine (BBR), a plant derived anti-obesity medication, increases adipose triglyceride lipase (ATGL) expression and basal rates of TG lipolysis in adipose tissue [26]. This evidence concerns the gene PNPLA2 and obesity due to melanocortin 4 receptor deficiency.